The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome

被引:141
作者
Baird, TA
Parsons, MW
Barber, PA
Butcher, KS
Desmond, PM
Tress, BM
Colman, PG
Jerums, G
Chambers, BR
Davis, SM
机构
[1] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic 3050, Australia
[2] Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic 3050, Australia
[3] Royal Melbourne Hosp, Dept Endocrinol & Diabet, Melbourne, Vic 3050, Australia
[4] Austin & Repatriat Med Ctr, Dept Neurol, Melbourne, Vic, Australia
[5] Austin & Repatriat Med Ctr, Dept Endocrinol & Diabet, Melbourne, Vic, Australia
关键词
review; diabetes mellitus; hyperglycaemia; cerebrovascular disease;
D O I
10.1054/jocn.2002.1081
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Diabetes mellitus is a complex metabolic syndrome with significant effects on the systemic and cerebral vasculature. The incidence and severity of ischaemic stroke are increased by the presence of diabetes, and outcome from stroke is poorer. More than one third of patients admitted with acute stroke are hyperglycaemic at presentation. Reasons for the altered prognosis in diabetes associated stroke are multifactorial. A direct influence of hyperglycaemia at the time of ischaemia is likely to be important. The use of novel methods to delineate stroke topography and pathophysiology such as MR spectroscopy, diffusion and perfusion weighted MRI appear helpful in delineating the effects of hyperglycaemia on stroke pathophysiology. Randomised clinical trials to determine optimal management for patients with hyperglycaemia following stroke are ongoing. Such trials will determine if aggressive control of acute hyperglycaemia following stroke has similar benefits to that observed following acute myocardial infarction. Clinicians responsible for stroke patients should be aware of the importance of adequate glycaemic control in both primary and secondary prevention of stroke. (C) 2002 Published by Elsevier Science Ltd.
引用
收藏
页码:618 / 626
页数:9
相关论文
共 116 条
[91]  
SALENIUS JP, 1990, J CARDIOVASC SURG, V31, P162
[92]   Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia the Glucose Insulin in Stroke Trial (GIST) [J].
Scott, JF ;
Robinson, GM ;
French, JM ;
O'Connell, JE ;
Alberti, KGMM ;
Gray, CS .
STROKE, 1999, 30 (04) :793-799
[93]   Blood pressure response to glucose potassium insulin therapy in patients with acute stroke with mild to moderate hyperglycaemia [J].
Scott, JF ;
Robinson, GM ;
French, JM ;
O'Connell, JE ;
Alberti, KGMM ;
Gray, CS .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (03) :401-404
[94]   EUROPEAN STROKE PREVENTION STUDY - EFFECTIVENESS OF ANTIPLATELET THERAPY IN DIABETIC-PATIENTS IN SECONDARY PREVENTION OF STROKE [J].
SIVENIUS, J ;
LAAKSO, M ;
RIEKKINEN, P ;
SMETS, P ;
LOWENTHAL, A .
STROKE, 1992, 23 (06) :851-854
[95]   DIABETES, OTHER RISK-FACTORS, AND 12-YR CARDIOVASCULAR MORTALITY FOR MEN SCREENED IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
STAMLER, J ;
VACCARO, O ;
NEATON, JD ;
WENTWORTH, D .
DIABETES CARE, 1993, 16 (02) :434-444
[96]   DIABETES-MELLITUS AND EARLY MORTALITY FROM STROKE [J].
STORM, T ;
HILDEBRANDT, P ;
SYKULSKI, R ;
LARSEN, J .
BRITISH MEDICAL JOURNAL, 1985, 291 (6508) :1577-1577
[97]   Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus [J].
Toyry, JP ;
Niskanen, LK ;
Lansimies, EA ;
Partanen, KPL ;
Uusitupa, MIJ .
STROKE, 1996, 27 (08) :1316-1318
[98]  
TRACEY F, 1993, Q J MED, V86, P439
[99]   Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland [J].
Tuomilehto, J ;
Borch-Johnsen, K ;
Molarius, A ;
Forsén, T ;
Rastenyte, D ;
Sarti, C ;
Reunanen, A .
DIABETOLOGIA, 1998, 41 (07) :784-790
[100]   Diabetes mellitus as a risk factor for death from stroke - Prospective study of the middle-aged Finnish population [J].
Tuomilehto, J ;
Rastenyte, D ;
Jousilahti, P ;
Sarti, C ;
Vartiainen, E .
STROKE, 1996, 27 (02) :210-215